Richard Silverman, PhD, is a Northwestern University chemist whose name bears the building. His experimentation led to the ...
Protein aggregation exhibits a dual role in biology, especially in neural systems. While pathogenic aggregates of proteins such as Aβ, tau, and α-synuclein ...
Detailed price information for Bioage Labs Inc (BIOA-Q) from The Globe and Mail including charting and trades.
Lifordi Immunotherapeutics and other biotechnology companies are using antibodies to precisely target drugs in the body.
For decades, Alzheimer’s disease has been described as a one‑way street, a slow erosion of memory that could at best be ...
Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.
Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...
Researchers have identified the specific structural loops in G-quadruplex DNA that allow it to act as a chaperone, preventing ...
At the recent ELRIG Drug Discovery conference, Technology Networks<i/> spoke with Dr. Kundan Sharma to learn more about how cell-free expression platforms are transforming membrane protein research.
You think you’re fine. Your family and friends think you’re fine. But, just maybe, you’re not. Maybe you already have Alzheimer’s disease, but you just don’t know it yet, because it can begin ...
Artificial intelligence (AI) is revolutionising the field of drug discovery and disease modelling, with a significant impact ...
We can replace joints, lenses, even organs—but not the brain. As neuroscience unravels the mechanisms of neurodegeneration, ...